Recursion Pharmaceuticals, Inc.RXRXNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending lower, above historical average.
Left:
||||
Price-to-book ratio
Latest
1.79
↑ 145% above average
Average (5y)
-4.02
Historical baseline
Range
High:5.37
Low:-24.02
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 1.79 | -59.5% |
| 2023 | 4.42 | +58.7% |
| 2022 | 2.79 | -48.1% |
| 2021 | 5.37 | +137.1% |
| 2020 | -14.47 | +39.8% |
| 2019 | -24.02 | - |